BIT 5.00% 1.9¢ biotron limited

Funding Structure, page-134

  1. 14,032 Posts.
    lightbulb Created with Sketch. 2393
    I think a CR might be a bit pointless at this stage - they would be prudent to wait until a positive announcement on FDA approval. That would get some investor interest and the BIT could take advantage of a higher SP value.

    Any FDA approval would indeed have to be released to the market so we can assume that this is still pending.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.